This playbook shows how to build a winning strategy by tackling the most pressing CGT logistics challenges with practical solutions. In the years since the first FDA-approved CAR-T therapy, manufacturers have driven rapid progress in this next generation of treatments. But as more cell and gene therapies (CGTs) approach commercialization, manufacturers must navigate a complex logistics environment. Each CGT is complex and unique, requiring innovative solutions for ordering, storage and delivery. Manufacturers need a reimagined strategy that’s built for speed, cost control and seamless experiences. This playbook shows how to build a winning strategy by tackling the most pressing challenges with practical solutions. Highlights include: A standardized platform to manage high costs, streamline ordering and enable single-sign-on across brands A strategic approach to protect sensitive products from environmental volatility and temperature deviations A solution to overcome industry gaps and ensure CGTs reach the right place at the right time, down to the final mile
